Global Bosimilar Market to Be Worth US$ 5.85 Billion by 2018
With around 40% of the biologic sales to be off-patent by 2015, biosimilars represent a huge opportunity area for companies. In 2013, the global biosimilar market stood at around US$ 1 Billion. Though the current biosimilars market is small, future of the market looks optimistic on factors including the need for affordable healthcare and rising clarity in regulatory frameworks in the US and emerging countires of India, China and South Korea. Backed by these factors among others, the market is...
View full press release